Antithrombotics and Cancer: Evidence for Survival Benefit

Publisher： Karger

E-ISSN： 1424-8840|33|1|67-68

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.1, 2003-09, pp. : 67-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

No Survival Benefit for Patients with Treatment in Certified Breast Centers—A Population‐based Evaluation of German Cancer Registry Data

By  

THE BREAST JOURNAL, Vol. 21, Iss. 5, 2015-09 ,pp. : 490-500

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population‐based study of bladder cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developing an objective marker to optimize patient selection and predict survival benefit in early‐phase cancer trials

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 262-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgery of primary tumour has survival benefit in metastatic breast cancer with single‐organ metastasis, especially bone

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 4, 2015-04 ,pp. : 240-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Facilitating access to evidence – a benefit to the profession

By Froude Elspeth   Craik Christine  

The British Journal of Occupational Therapy, Vol. 73, Iss. 12, 2010-12 ,pp. : 569-569

College of Occupational Therapists

Access to resources Recommend Favorite